6ix — Find Your Next Investment

Discover investor relations events, company profiles, and investment opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
21m ago	Delivra Health Brands Enters into Licence Agreement with Peak Processing to Manufacture and Distribute Its Topical Brand LivRelief Infused(TM)
22m ago	Patterson-UTI Energy Reports Financial Results for the Quarter Ended March 31, 2026
22m ago	Liberty Energy Inc. Announces First Quarter 2026 Financial and Operational Results
45m ago	TransUnion Applauds FHFA, HUD for Advancing VantageScore in Mortgage Lending
45m ago	Oxford Square Capital Corp. Schedules First Quarter 2026 Earnings Release and Conference Call for April 29, 2026

About

Abbvie Inc (NYSE:ABBV) — investor relations, events, news, and company updates on 6ix.

Latest News

AbbVie Selects North Carolina for New $1.4 Billion Manufacturing Campus

Middle East and Africa Biosimilars Market Trends Report 2026-2035, Profiles of AbbVie, Amgen, Biocon, Celltrion, Dr. Reddy's, Pfizer, Roche, Samsung, Sandoz, Teva, Viatris

Haisco Enters into Exclusive License Agreement with AbbVie to Develop Novel Medicines for Pain

AbbVie Showcases Late‑Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE®) in Platinum‑Sensitive Ovarian Cancer (PSOC) at SGO 2026

/C O R R E C T I O N -- AbbVie/

Financials

Revenue

$61.16 B

Market Cap

$369.39 B

P/E Ratio

88.49

EPS

2.36

Dividend Yield

3.09%

Community Chat

Ask AI